Genprex, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period
Genprex, Inc. (GNPX) had Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period of 327.64 thousand shares as of 2020-12-31, per its 10-Q filed 2021-05-17.
Discontinued › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod · last filed 2021-05-17
- Genprex, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2020-09-30 was 0.00 shares.
- Genprex, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2019-12-31 was 205.25K shares.
- Genprex, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2019-09-30 was 0.00 shares.
- Genprex, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for the quarter ending 2019-06-30 was 0.00 shares.
- Genprex, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2019 was 297.06K shares, a 132.82% increase from fiscal 2018.
- Genprex, Inc. share-based compensation arrangement by share-based payment award, options, expirations in period for fiscal 2018 was 127.59K shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period 12 month |
|---|---|---|---|---|---|
| 2020-12-31 | 327.64K shares 10-Q · filed 2021-05-17 | ||||
| 2020-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12 | 164.84K shares 10-Q · filed 2020-11-12 | |||
| 2020-06-30 | 164.84K shares 10-Q · filed 2020-08-11 | ||||
| 2019-12-31 | 205.25K shares derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-26 | 205.25K shares derived: sum of 2 quarters · filed 2021-03-26 | 205.25K shares derived: sum of 3 quarters · filed 2021-03-26 | 297.06K shares 10-K · filed 2021-03-26 | |
| 2019-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-14 | 0.00 shares derived: sum of 2 quarters · filed 2019-11-14 | 91.81K shares 10-Q · filed 2019-11-14 | 91.81K shares derived: sum of 4 quarters · filed 2020-03-30 | |
| 2019-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q/A 3 month · filed 2019-08-13 | 91.81K shares 10-Q · filed 2019-08-13 | 91.81K shares derived: sum of 3 quarters · filed 2020-03-30 | ||
| 2019-03-31 | 91.81K shares 10-Q/A · filed 2019-05-20 | 91.81K shares derived: sum of 2 quarters · filed 2020-03-30 | |||
| 2018-12-31 | 0.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | 127.59K shares 10-K · filed 2020-03-30 | |||
| 2018-09-30 | 127.59K shares 10-Q · filed 2018-11-14 | ||||
| 2017-12-31 | 0.00 shares 10-Q · filed 2018-11-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Alaunos Therapeutics, Inc. (TCRT) | United States | $0.003B | -1.44 |
| Silo Pharma, Inc. (SILO) | United States | $0.003B | -1.57 |
| GeoVax Labs, Inc. (GOVX) | United States | $0.003B | -0.45 |
| Petros Pharmaceuticals, Inc. (PTPI) | United States | $0.003B | |
| Sunshine Biopharma Inc. (SBFM) | $0.003B | ||
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Aptevo Therapeutics Inc. (APVO) | United States | $0.003B | |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |